Dynamic Changes of Ductus Arteriosus in < 31 Weeks Preterm Infants: an Observational Study
Condition(s) studied
Investigational drug(s) / intervention(s)
observation group: in the group, no intervention was given, and the preterm infants were diagnosed with respiratory distress syndrome(RDS)
control group: in the group, no intervention was given, but the preterm infants were diagnosed without respiratory distress syndrome(RDS)
Study summary
The ductus arteriosus quickly closes itself. is an important channel connecting the maternal fetal circulation before birth. After birth, this ductus arteriosus generally no longer has a physical function, so ductus arteriosus quickly closes itself. The persistent presence of ductus arteriosus leads to significant pressure changes in the systemic and pulmonary circulation, which have adverse effects on extremely/very premature infants. Therefore, persistent patent ductus arteriosus (PDA) is a systemic disease.
Eligibility
Primary outcome measure(s)
- the incidence of patent ductus arteriosus(PDA) — three months after birth
when did the ductus arteriosus close - dynamic changes of ductus arteriosus in diameter, velocity and direction of blood flow — after admission, 12 hour, 24 hour, 48 hour, 72 hour, 96 hour, 120 hour, 144 hour, 168 hour, 192 hour, 216 hour, 240 hour and 2 weeks or any time of ductus arteriosus closed
dynamic changes of ductus arteriosus in diameter, velocity and direction of blood flow were measured
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Women and Children's hospital of Chonqing Medical University | Chongqing | Chongqing Municipality |
More Daping Hospital and the Research Institute of Surgery of the Third Military Medical University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06950164 on ClinicalTrials.gov ↗ ← All trials in China